-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Champions Oncology, Inc. Operating Income (Loss) for the quarter ending January 31, 2025 was $4.5M.
- Champions Oncology, Inc. Operating Income (Loss) for the twelve months ending January 31, 2025 was $6.29M.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2023 was -$7.36M, a 40% decline from 2022.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2022 was -$5.26M, a 966% decline from 2021.
- Champions Oncology, Inc. annual Operating Income (Loss) for 2021 was $607K, a 65.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)